Botulinum toxin (BoNT) is used for a range of applications, but when injected it can diffuse into the surrounding tissue and give rise to adverse effects. A new study shows that a subtle modification of an FDA-approved form of BoNT enhances binding to the nerve cells and improves the drug's potency and safety.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/03/200317155843.htm
No comments:
Post a Comment